Avanos Medical (NYSE:AVNS – Get Free Report) is projected to release its earnings data before the market opens on Tuesday, February 18th. Analysts expect Avanos Medical to post earnings of $0.40 per share and revenue of $177.23 million for the quarter.
Avanos Medical Trading Up 0.8 %
Shares of NYSE AVNS opened at $16.64 on Tuesday. Avanos Medical has a 1-year low of $14.98 and a 1-year high of $25.36. The company has a 50-day moving average of $16.74 and a two-hundred day moving average of $20.33. The company has a market cap of $764.68 million, a PE ratio of 48.94 and a beta of 0.98. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.
Wall Street Analysts Forecast Growth
Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.
About Avanos Medical
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Stories
- Five stocks we like better than Avanos Medical
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Merck: 4 No-Brainer Reasons to Buy This Dip
- 3 REITs to Buy and Hold for the Long Term
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.
